EUVIMEDEUVIMED entdecken
Crossref

LncRNA MIR17HG accelerates the development of atherosclerosis by promoting macrophage pyroptosis through the miR-301a-3p/TXNIP pathway

Yu-Ping Wang, Xian Liu, Xiao-Dan Xu, Lei Hui, Guang-Hong Xu, Meng-Qing Ma, Lin Zhu, Kun Ren

International Immunopharmacology · 2025-10 · 164 · 115407

DOI: 10.1016/j.intimp.2025.115407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-10. Verfasst von Yu-Ping Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, Anhui University of Chinese Medicine, Hefei 230012, Anhui, PR China. Hauptthemen laut MEDLINE: Pyroptosis, MicroRNAs, Macrophages, Atherosclerosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Anhui University of Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation, immune dysregulation, and cell death within the arterial wall. While extensive research has been devoted to the understanding of its molecular pathogenesis, novel regulatory factors contributing to its progression remain to be identified. Macrophage pyroptosis and the subsequent inflammatory response play a central role in atherogenesis. Recent evidence has implicated long non-coding RNAs (lncRNAs) in macrophage dysfunction and vascular inflammation; however, the precise roles of specific lncRNAs in pyroptosis-mediated atherogenesis are still unclear. In this study, we identified lncRNA MIR17HG as a potential regulator of macrophage pyroptosis and atherosclerosis progression. Exposure of THP-1-derived macrophages to ox-LDL induced a dose-dependent increase in MIR17HG expression. Silencing of MIR17HG significantly reduced the expression of pyroptosis-related factors, caspase-1 activity, LDH release, proinflammatory cytokine secretion, and plasma membrane disruption in ox-LDL-treated macrophages, indicating attenuation of pyroptosis. These effects were reversed by TXNIP overexpression or transfection with a miR-301a-3p inhibitor. Mechanistically, MIR17HG functioned as a competing endogenous RNA (ceRNA), sponging miR-301a-3p to upregulate TXNIP expression and activate the NLRP3 inflammasome. Consistently, MIR17HG knockdown reduced plaque burden, improved plasma lipid profile, and alleviated inflammation in high-fat diet-fed apoE-/- mice; these protective effects were abrogated by administration of a miR-301a-3p antagomir. Collectively, our findings reveal that MIR17HG promotes atherosclerosis by enhancing macrophage pyroptosis through the miR-301a-3p/TXNIP/NLRP3 axis, offering new insight into the lncRNA-mediated regulation of vascular inflammation and plaque development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisMicroRNAsMacrophagesAtherosclerosisRNA, Long NoncodingCarrier ProteinsAnimalsHumansMiceMice, Inbred C57BLLipoproteins, LDLMaleTHP-1 CellsSignal TransductionNLR Family, Pyrin Domain-Containing 3 ProteinMice, KnockoutThioredoxins

Stichwörter der Autor:innen

AtherosclerosisMacrophage pyroptosislncRNA MIR17HG

Substanzen

MicroRNAsRNA, Long NoncodingCarrier Proteinsoxidized low density lipoproteinLipoproteins, LDLTxnip protein, mouseNLR Family, Pyrin Domain-Containing 3 ProteinMirn17 microRNA, mouseThioredoxins

Autor:innen und Institutionen

  • College of Nursing, Anhui University of Chinese Medicine, Hefei 230012, Anhui, PR China.
  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, PR China.
  • Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, PR China.
  • College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, PR China. Electronic address: 657922023@qq.com.
  • College of Nursing, Anhui University of Chinese Medicine, Hefei 230012, Anhui, PR China; Laboratory of Geriatric Nursing and Health, Anhui University of Traditional Chinese Medicine, Hefei 230012, Anhui, PR China. Elect…

Förderung

  • Anhui University of Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y. P., Liu, X., Xu, X. D., Hui, L., Xu, G. H., Ma, M. Q., Zhu, L., & Ren, K. (2025). LncRNA MIR17HG accelerates the development of atherosclerosis by promoting macrophage pyroptosis through the miR-301a-3p/TXNIP pathway. International Immunopharmacology, 164, 115407. https://doi.org/10.1016/j.intimp.2025.115407

Vancouver

Wang YP, Liu X, Xu XD, Hui L, Xu GH, Ma MQ, et al. LncRNA MIR17HG accelerates the development of atherosclerosis by promoting macrophage pyroptosis through the miR-301a-3p/TXNIP pathway. International Immunopharmacology. 2025;164:115407. doi:10.1016/j.intimp.2025.115407

BibTeX
@article{Wang2025,
  author = {Wang, Yu-Ping and Liu, Xian and Xu, Xiao-Dan and Hui, Lei and Xu, Guang-Hong and Ma, Meng-Qing and Zhu, Lin and Ren, Kun},
  title = {LncRNA MIR17HG accelerates the development of atherosclerosis by promoting macrophage pyroptosis through the miR-301a-3p/TXNIP pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {164},
  pages = {115407},
  doi = {10.1016/j.intimp.2025.115407}
}
Kostenlos starten →